FDA-accepted monoclonality assurance on the Beacon Optofluidic System for cell line development

10 Nov 2022

In this application note, Berkeley Lights presents its Beacon® Optofluidic System for cell line development.

Beacon® Optofluidic System

Bruker Cellular Analysis

Understand the Life of Single Cells. The Beacon system unites optics, fluidics, and imaging to deliver high‑parameter, real‑time functional analysis of up to 60,000 live single cells. With automated scalability and downstream recovery, it accelerates therapeutic antibody discovery, vaccine development, immune profiling, cell therapy, and cell line development.

(0)

Links

Tags

FDA-accepted monoclonality assurance on the Beacon Optofluidic System for cell line development